ART-FORSEE is a collaborative research network initiated by researchers and clinicians at Haukeland University Hospital, Stavanger University Hospital, the University of Bergen, and Western Norway University of Applied Sciences to advance the development and clinical integration of adaptive radiotherapy.
Adaptive radiotherapy is an emerging approach that could significantly enhance the precision and personalization of treatment by allowing radiation plans to be updated in response to anatomical changes during the course of therapy.
Proton therapy, with its superior dose distribution and sparing of healthy tissues, represents a major advancement in precision radiotherapy. Integrating adaptation with proton therapy has the potential to extend its benefits to anatomically complex regions, where variability can otherwise limit its use.
ART-FORSEE explores adaptive strategies across both photon and proton therapy and facilitates the adoption in departments with varying levels of technological infrastructure. Emphasis is therefore placed on integrating advanced imaging and automation to improve workflow and efficiency. For proton therapy, the project focuses on clinically challenging regions such as the thorax and head and neck while also addressing biological and physical uncertainties.
Through clinical studies, in-silico simulations, and workflow development, ART-FORSEE will provide new insights into the clinical potential of adaptive radiotherapy.